Multiplex PCR (polymerase chain reaction) detection method for virus items of rats and mice
Through the design of multiple fluorescence quantitative PCR technology and the design of specific primer probes, the problem of false negative virus detection and low simultaneous detection efficiency of multiple viruses in the prior art is solved, and the simultaneous detection of four viruses with high sensitivity and high specificity is achieved. , significantly improves detection efficiency and accuracy.
Patent Information
- Application Number
- CN202411278472.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2024-11-26
AI Technical Summary
Existing experimental animal virus detection methods such as ELISA and IFA are difficult to detect viruses during the periodic detoxification stage of viruses, which can easily lead to false negative results, and the detection efficiency of multiple viruses is low.
Multiple fluorescence quantitative PCR detection method was used to design specific primers and probes for mouse hepatitis virus, Sendai virus, pneumonia virus and reovirus type III, combined with fluorescence quantitative PCR technology, and simultaneously detect four in a single tube reaction. A virus was used as an internal reference to monitor the nucleic acid extraction quality and PCR reaction effectiveness of the sample.
It has achieved efficient and quick detection of four viruses simultaneously, with detection sensitivity of 30-100 copies, sample concentration as low as 1.0ng/μl, and the accuracy and repetition of the detection results, which has improved the efficiency of pathogenic microorganism detection in experimental animals.
Smart Images

Figure CN119020536A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of mouse disease detection methods, and in particular to a multiplex PCR detection method for mouse and rat virus items. Background Art
[0002] Laboratory animals are widely used in life sciences, biomedicine, food and other fields, making great contributions to human scientific progress and healthy life. The quality of laboratory animals directly affects the accuracy of experiments in many of the above fields, and is also related to the health of laboratory animal practitioners and animal experiment operators. According to the requirements of the national standard GB 14922-2022 "Microbiology, Parasitology Grade and Monitoring of Laboratory Animals", laboratory animal pathogenic microorganism detection includes viruses, bacteria and external parasites, among which mouse hepatitis virus, Sendai virus, pneumonia virus and reovirus type III are the four most common viruses that laboratory mice are susceptible to.
[0003] Mouse Hepatitis Virus (MHV) is a highly contagious RNA virus of the coronavirus family. Infection of experimental animals, especially immunodeficient mice, with MHV can have significant and lasting effects on the immune system, leading to prolonged or more severe infections including viruses, bacteria and parasites.
[0004] Sendai virus (SV) is a Paramyxoviridae RNA virus that is mainly transmitted through aerosols and respiratory secretions and is highly contagious. When experimental animals are infected with SV, they are prone to secondary bacterial infection, leading to the death of the animals. Experimental animals infected with SV are not suitable for scientific research.
[0005] Pneumonia Virus of Mice (PVM) is also a Paramyxoviridae RNA virus. Infection in experimental animals can cause interstitial pneumonia accompanied by weight loss, lung dysfunction, and shortened lifespan. Experimental animals infected with PVM are not suitable for scientific research.
[0006] Mouse reovirus type III (REO-3) is a Reoviridae RNA virus that can be transmitted through fecal-oral and oral secretions. Infected experimental mice show symptoms such as stunted growth and diarrhea. Experimental animals infected with REO-3 can affect scientific research such as cytokine levels, tumor transplantation and liver function.
[0007] The detection of the above four viruses mainly adopts immunological methods, such as enzyme-linked immunosorbent assay (ELISA) and time-resolved immunofluorescence (IFA). These methods can only be detected after the corresponding antibodies are produced in the infected animal. For periodic viruses, it is easy to cause false negative results when there is no antibody produced in the body during the detoxification stage. Fluorescence quantitative PCR (Real-time PCR) technology refers to adding fluorescent groups to the PCR reaction system, using the accumulation of fluorescent signals to monitor the entire PCR process in real time, and finally using the standard curve to quantitatively analyze the unknown template. Fluorescence quantitative PCR technology has the characteristics of high throughput, strong specificity, high sensitivity, fully closed reaction, high degree of automation, and fast speed. It is widely used in many fields such as clinical disease diagnosis and animal disease detection.
[0008] Multiplex PCR (multiplex Polymerase Chain Reaction, mPCR) is also called composite PCR. Its basic principle is the same as conventional PCR. The difference is that more than one pair of primers are added to the multiplex PCR reaction system. Each pair of primers binds to the corresponding part of the template, and finally amplifies more than one target DNA fragment. Multiplex PCR can be used for multiple pathogenic microorganisms at the same time. Compared with traditional PCR, multiplex PCR has the advantages of high efficiency, simplicity, low cost, and strong system. Therefore, a multiplex PCR detection method for mouse and rat virus items is proposed. Summary of the invention
[0009] The object of the present invention is to provide a multiplex PCR detection method for mouse and rat viruses to solve the problems raised in the above background technology.
[0010] To achieve the above object, the present invention provides the following technical solution: a multiplex PCR detection method for virus items in rats and mice, comprising the following steps:
[0011] S1. Prepare the sample nucleic acid to be tested;
[0012] S2. Prepare negative control, positive control and no-template control;
[0013] S3, adding the sample nucleic acid to be tested, the negative quality control product, the positive quality control product and the template-free control to the fluorescent quantitative PCR reaction system respectively;
[0014] S4. Perform PCR amplification reaction on a fluorescent quantitative PCR instrument, and detect the specific amplification curves of the four viruses through the FAM / VIC / ROX / CY5 channels;
[0015] S5. Determine whether the sample to be tested contains the virus based on the amplification curve results of the fluorescent quantitative PCR instrument.
[0016] Preferably, in the above-mentioned S1, the sample to be tested is a nucleic acid extracted from an experimental animal sample, and the experimental animal sample includes but is not limited to feces, intestinal swabs, oral swabs and tissues.
[0017] Preferably, in the above-mentioned S2, the positive control product can obtain 4 amplification curves of different fluorescent labels through amplification, and the negative control product is enzyme-free sterile water.
[0018] Preferably, in the above-mentioned S3, the PCR amplification reaction uses RNA as a template, and specific primers and probes for four viruses are added.
[0019] Preferably, the above: the probe end is quenched with MGB and BHQ3 and fluorescently labeled with FAM / VIC / ROX / CY5 / CY5.5;
[0020] The final concentration of the PCR amplification reaction system is as follows: 1-10×PCR Mix contains Taq enzyme, dNTPs, Tris·Cl, potassium chloride, magnesium sulfate and magnesium chloride.
[0021] Preferably, in the above: in S4, the four viruses are mouse hepatitis virus, Sendai virus, pneumonia virus and reovirus type III and mouse GAPDH gene internal reference.
[0022] Preferably, the primers and probes used in the above-mentioned PCR amplification reaction are designed for the above-mentioned four conserved regions of viral nucleic acid fragments.
[0023] Preferably, the final concentration of the PCR amplification reaction is as follows: 1-10×PCR Mix, 0.1-1 μM forward primer, 0.1-1 μM reverse primer, 0.1-0.5 μM probe and more than 1.0 ng / μl template nucleic acid.
[0024] Preferably, the specific process of the fluorescent quantitative PCR amplification reaction is as follows:
[0025] First, perform pre-denaturation at 92-97°C for 5-10 minutes;
[0026] Then enter the polymerase chain reaction amplification stage, denaturation at 92-97°C for 10-30s, annealing and extension at 50-65°C for 10-30s, and perform 35-45 cycles.
[0027] Preferably, in the above step S5, the specific process of interpreting the fluorescence quantitative PCR results is as follows:
[0028] The positive control product has an amplification curve and a Ct value of <35;
[0029] Negative control products have no amplification curve or the amplification curve Ct value is ≥35;
[0030] The GAPDH internal reference gene of the sample to be tested has an amplification curve and a Ct value of <35;
[0031] When the sample to be tested has an amplification curve in the different fluorescence channels detected and the Ct value is less than 35, it is determined to be positive for the corresponding virus.
[0032] Compared with the prior art, the present invention adopts the above technical solution and has the following technical effects:
[0033] 1. The present invention integrates a multiplex fluorescent quantitative PCR detection method for mouse hepatitis virus, Sendai virus, pneumonia virus and reovirus type III. The present invention includes four common viruses in experimental animals, has high detection efficiency, and a single-tube reaction can detect the above four viruses at the same time; it is convenient and fast, and the detection can be completed within 2 hours. The test results have good accuracy and repeatability, and have certain guiding significance for the detection of pathogenic microorganisms in experimental animals.
[0034] Second, the present invention ensures high sensitivity and specificity of detection by designing specific primers and probes for the conservative region of viral nucleic acid fragments. The detection sensitivity can reach 30-100 copies, and the sample concentration is as low as 1.0ng / μl, which can accurately identify the presence of trace amounts of viruses. The mouse GAPDH gene is introduced as an internal reference. By detecting the amplification of the internal reference gene, the extraction quality of the sample nucleic acid and the effectiveness of the PCR reaction can be monitored. The primer probe test with multiple concentration combinations determines the optimal reaction conditions, which makes the PCR amplification effect the best, further improving the accuracy of the detection. This method realizes the simultaneous detection of four viruses: mouse hepatitis virus, Sendai virus, pneumonia virus and reovirus type III, greatly improving the detection efficiency. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0036] Figure 1 This is a diagram of the GAPDH gene amplification results of the present invention;
[0037] Figure 2 This is a diagram of the first primer probe screening result of the present invention;
[0038] Figure 3 This is a diagram of the second primer probe screening result of the present invention;
[0039] Figure 4 This is the result diagram of concentration combination 1 of the present invention;
[0040] Figure 5 This is the result diagram of concentration combination 2 of the present invention;
[0041] Figure 6 This is the result diagram of concentration combination 3 of the present invention;
[0042] Figure 7 This is the result diagram of concentration combination 4 of the present invention;
[0043] Figure 8 This is the result diagram of sample 1 of the present invention;
[0044] Fig. 9 This is the result diagram of sample 2 of the present invention;
[0045] Fig.10 This is the result diagram of sample 3 of the present invention;
[0046] Fig.11 This is the result diagram of sample 4 of the present invention;
[0047] Fig.12 This is the result diagram of sample 5 of the present invention;
[0048] Fig.13 This is the result diagram of sample 6 of the present invention;
[0049] Fig.14 This is the result diagram of sample 7 of the present invention. DETAILED DESCRIPTION
[0050] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0051] It should be noted that the structures, proportions, sizes, etc. illustrated in the drawings of this specification are only used to match the contents disclosed in the specification for people familiar with this technology to understand and read, and are not used to limit the conditions under which this application can be implemented. Therefore, they have no substantive technical significance. Any structural modification, change in proportional relationship or adjustment of size should still fall within the scope of the technical content disclosed in this application without affecting the effects and purposes that can be achieved by this application.
[0052] Example
[0053] See also Figure 1-14The present invention provides a technical solution: a multiplex PCR detection method for virus items in mice and rats, comprising the following steps:
[0054] S1. Prepare the sample nucleic acid to be tested;
[0055] The sample to be tested is nucleic acid extracted from experimental animal samples, and the experimental animal samples include but are not limited to feces, intestinal swabs, oral swabs and tissues.
[0056] Design corresponding primer and probe sequences for the conserved regions of the four viral nucleic acid fragments, and then design a pair of primer probes for the mouse internal reference GAPDH gene, use a magnetic bead method pathogenic microorganism nucleic acid extraction kit to extract sample nucleic acid, use real-time fluorescence quantitative PCR technology to amplify the target fragment, and finally detect whether the corresponding fluorescent signal is generated in the reaction system through PCR reaction to determine whether the sample to be tested contains one or more of the above four viruses;
[0057] S2. Prepare negative control, positive control and no-template control;
[0058] The positive quality control product can obtain 4 different fluorescent labeled amplification curves through amplification, and the negative quality control product is enzyme-free sterile water.
[0059] S3, adding the sample nucleic acid to be tested, the negative quality control product, the positive quality control product and the template-free control to the fluorescent quantitative PCR reaction system respectively;
[0060] The PCR amplification reaction uses RNA as a template, adds specific primers and probes for four viruses, uses MGB and BHQ3 to quench the probe ends, and uses FAM / VIC / ROX / CY5 / CY5.5 fluorescent labels; the final concentration composition of the PCR amplification reaction system is: 1-10×PCR Mix contains Taq enzyme, dNTPs, Tris·Cl, potassium chloride, magnesium sulfate and magnesium chloride.
[0061] The design of mouse internal reference GAPDH gene primers and probes is as follows:
[0062] The mouse GAPDH gene sequence was found using the NCBI database, and the primer probes were designed using PrimerPrimer 5.0 software, and compared to the homologous regions on the 4 viral nucleic acid sequences to be tested;
[0063] The internal reference gene and corresponding primer and probe sequences are as follows:
[0064]
[0065]
[0066] Mouse nucleic acid was used as a template for fluorescence quantitative PCR experiments. The primer probe amplification effect of the internal reference gene GAPDH was good, and there was no cross reaction between the positive references of MHV, SV, PVM and Reo-3. Figure 1 This is the result of GAPDH gene amplification, so GAPDH was selected as the internal reference of the detection system;
[0067] The above four virus detection systems are placed in a separate detection well for detection. The probes used to amplify the four viruses in the reaction well are labeled with different fluorescent groups, namely FAM, VIC, ROX and CY5. The GAPDH internal reference gene is labeled with the CY5.5 fluorescent group. Whether the internal reference gene GAPDH is amplified can be used as a quality control condition for whether the sample nucleic acid is successfully extracted;
[0068] The genome sequences corresponding to the above four viruses were found in the NCBI database, and two pairs of primer probes were designed using Primer Primer 5.0 software. The designed primer probe sequences were compared with the genome sequences of other pathogenic microorganisms in the NCBI database to ensure the specificity of the designed primer probes.
[0069] Two pairs of each of the four synthesized viruses were combined with primers and probes according to different fluorescent markers to test the multiplex PCR amplification effect and whether there was non-specific amplification, and finally determine the optimal primer-probe combination. The primer-probe screening results are as follows: Figure 2 and Figure 3 ;
[0070] The optimized primer-probe combination was adjusted to determine the best reaction conditions. The primer-probe combinations of the four viruses were prepared into PCR reaction solutions with four different concentrations according to their respective combinations. The positive reference was used as a template for testing. It was found that the reaction fluorescence value and Ct value were optimal when the final concentration of the primer was 500 nM and the final concentration of the probe was 250 nM. Therefore, this concentration was used for subsequent testing.
[0071] The following are the data of primer-probe combinations with different concentrations:
[0072] Concentration combination 1 Concentration combination 2 Concentration combination 3 Concentration combination 4 Upstream primer 1000nM 500nM 1000nM 500nM Downstream primer 1000nM 500nM 1000nM 500nM Probe 500nM 250nM 250nM 500nM
[0073] Through the above data and Figure 4-7 It can be seen that the reaction fluorescence value and Ct value are optimal when the final concentration of primers is 500nM and the final concentration of probes is 250nM, so this concentration is used for subsequent tests;
[0074] S4. Perform PCR amplification reaction on a fluorescent quantitative PCR instrument, and detect the specific amplification curves of the four viruses through the FAM / VIC / ROX / CY5 channels. The PCR amplification reaction uses a fluorescent quantitative PCR detection platform;
[0075] The four viruses are mouse hepatitis virus, Sendai virus, pneumonia virus and reovirus type III and mouse GAPDH gene internal reference. The primers and probes used in the PCR amplification reaction are designed for the conserved regions of the above four viral nucleic acid fragments. The final concentration of the PCR amplification reaction consists of: 1-10×PCR Mix, 0.1-1μM forward primer, 0.1-1μM reverse primer, 0.1-0.5μM probe and more than 1.0ng / μl template nucleic acid.
[0076] The specific process of the fluorescent quantitative PCR amplification reaction is as follows:
[0077] First, perform pre-denaturation at 92-97°C for 5-10 minutes;
[0078] Then enter the polymerase chain reaction amplification stage, denaturation at 92-97°C for 10-30s, annealing and extension at 50-65°C for 10-30s, and perform 35-45 cycles.
[0079] S5. Determine whether the sample to be tested contains the virus based on the amplification curve results of the fluorescent quantitative PCR instrument.
[0080] The specific process of interpreting the fluorescence quantitative PCR results is as follows:
[0081] The positive control product has an amplification curve and a Ct value of <35;
[0082] Negative control products have no amplification curve or the amplification curve Ct value is ≥35;
[0083] The GAPDH internal reference gene of the sample to be tested has an amplification curve and a Ct value of <35;
[0084] When the sample to be tested has an amplification curve in the different fluorescence channels detected and the Ct value is less than 35, it is determined to be positive for the corresponding virus.
[0085] This detection method has the characteristics of high sensitivity and high specificity. Its detection sensitivity can reach 30-100 copies, and the sample concentration can be as low as 1.0ng / μl.
[0086] The following is an application example of virus detection in mice and rats:
[0087] Materials: Feces, oral swabs, positive quality control products, and negative quality control products of mice to be tested;
[0088] Instruments: SLAN-96 fluorescence quantitative PCR instrument, magnetic stand, vortex shaker, refrigerator, biological safety cabinet;
[0089] Reagents: Pathogen Nucleic Acid Extraction Kit (Thermo Fisher No. A42358), Invitrogen SuperScript IV One-Step RT-PCR Reagent (Thermo Fisher No. 12594025), UltraPure TM DNase / RNase-Free Water (ThermoFisher Catalog No. 10977015), TE Buffer (ThermoFisher Catalog No. 12090015);
[0090] Primer probe: Custom synthesized by Invitrogen, purity should reach HPLC grade;
[0091] The primers, probes and sequences are as follows:
[0092]
[0093] The primers were diluted to 100 μM in a dry powder state using TE solution according to the values provided by the primer synthesis company, and then mixed into an upstream and downstream primer mix, which was then diluted to a final concentration of 500 nM according to the following dilution method;
[0094]
[0095] Refer to the primer dilution method and dilute the probe to 250nM as follows:
[0096]
[0097] After completing the primer and probe dilution, prepare the reaction detection solution according to the following composition:
[0098] Test fluid components Volume per reaction (μL) Upstream Primer Mix 1.25 Downstream Primer Mix 1.25 Probe Mix 0.625 Total 3.125
[0099] Prepare the PCR reaction system according to the following components:
[0100] Reagent components 1 person PCRMix (μL) <![CDATA[2X Platinum TM SuperFi TM RT-PCR Master Mix]]> 25 Reaction test solution 3.125 <![CDATA[SuperScript TM IV RT Mix]]> 0.5 Sample DNA According to actual joining Total 50
[0101] After the PCR Mix is prepared, vortex and mix for 10 seconds, then centrifuge and dispense into 8 tubes. Add the processed samples or negative / positive / blank controls and use UltraPure TM Add DNase / RNase-Free Distilled Water to 50 μL, vortex mix for 10 seconds and centrifuge immediately;
[0102] Set up the PCR reaction program and perform the PCR reaction according to the following conditions:
[0103]
[0104]
[0105] After the experiment, the positive quality control product has an amplification curve and a Ct value of <35;
[0106] Negative control products have no amplification curve or the amplification curve Ct value is ≥35;
[0107] The GAPDH internal reference gene of the sample to be tested has an amplification curve and a Ct value of <35;
[0108] When the sample to be tested has an amplification curve in the different fluorescence channels detected and the Ct value is less than 35, it is determined as a positive test result for the corresponding virus;
[0109] According to the above specific technical scheme, 7 samples were tested, and the test results are as follows: Figure 8-14 , the results are summarized as follows:
[0110] Sample No. result 1 Negative 2 MHV positive 3 REO-3 positive 4 Negative 5 SV positive 6 Negative 7 PVM positive
[0111] In summary, the present invention integrates the multiplex fluorescence quantitative PCR detection method of mouse hepatitis virus, Sendai virus, pneumonia virus and reovirus type III. The present invention includes four common viruses in experimental animals, has high detection efficiency, and a single-tube reaction can detect the above four viruses at the same time; it is convenient and fast, and the detection can be completed within 2 hours. The test results have good accuracy and repeatability, which has certain guiding significance for the detection of pathogenic microorganisms in experimental animals.
[0112] By designing specific primers and probes for the conservative regions of viral nucleic acid fragments, the high sensitivity and specificity of the detection are ensured. The detection sensitivity can reach 30-100 copies, and the sample concentration is as low as 1.0ng / μl, which can accurately identify the presence of trace amounts of viruses. The mouse GAPDH gene is introduced as an internal reference. By detecting the amplification of the internal reference gene, the extraction quality of the sample nucleic acid and the effectiveness of the PCR reaction can be monitored. The primer probe test with multiple concentration combinations determines the optimal reaction conditions, which makes the PCR amplification effect the best, further improving the accuracy of the detection. This method realizes the simultaneous detection of four viruses: mouse hepatitis virus, Sendai virus, pneumonia virus and reovirus type III, greatly improving the detection efficiency.
[0113] It will be appreciated by those skilled in the art that the features described in the various embodiments and / or claims of the present invention may be combined and / or combined in various ways, even if such combinations and / or combinations are not explicitly described in the present invention. In particular, the features described in the various embodiments and / or claims of the present invention may be combined and / or combined in various ways without departing from the spirit and teachings of the present invention. All of these combinations and / or combinations fall within the scope of the present invention.
Claims
1. A multiplex PCR detection method for mouse and rat viruses, characterized in that: The following steps are involved: S1. Prepare the sample nucleic acid to be tested; S2. Prepare negative control, positive control and no-template control; S3, adding the sample nucleic acid to be tested, the negative quality control product, the positive quality control product and the template-free control to the fluorescent quantitative PCR reaction system respectively; S4. Perform PCR amplification reaction on a fluorescent quantitative PCR instrument, and detect the specific amplification curves of the four viruses through the FAM / VIC / ROX / CY5 channels; S5. Determine whether the sample to be tested contains the virus based on the amplification curve results of the fluorescent quantitative PCR instrument.
2. A multiplex PCR detection method for mouse and rat viruses according to claim 1, characterized in that: In S1, the sample to be tested is a nucleic acid extracted from an experimental animal sample, and the experimental animal sample includes but is not limited to feces, intestinal swabs, oral swabs and tissues.
3. A multiplex PCR detection method for mouse and rat viruses according to claim 1, characterized in that: In S2, the positive quality control product can obtain 4 different fluorescent labeled amplification curves through amplification, and the negative quality control product is enzyme-free sterile water.
4. A multiplex PCR detection method for mouse and rat viruses according to claim 1, characterized in that: In S3, the PCR amplification reaction uses RNA as a template and adds specific primers and probes for four viruses.
5. A multiplex PCR detection method for rat and mouse viruses according to claim 4, characterized in that: The probe end is quenched with MGB and BHQ3 and fluorescently labeled with FAM / VIC / ROX / CY5 / CY5.5; The final concentration of the PCR amplification reaction system is as follows: 1-10×PCR Mix contains Taq enzyme, dNTPs, Tris·Cl, potassium chloride, magnesium sulfate and magnesium chloride.
6. The multiplex PCR detection method for mouse and rat viruses according to claim 1, characterized in that: In S4, the four viruses are mouse hepatitis virus, Sendai virus, pneumonia virus and reovirus type III and mouse GAPDH gene internal reference.
7. A multiplex PCR detection method for rat and mouse viruses according to claim 6, characterized in that: The primers and probes used in the PCR amplification reaction are designed for the above four conserved regions of viral nucleic acid fragments.
8. A multiplex PCR detection method for mouse and rat viruses according to claim 7, characterized in that: The final concentration of the PCR amplification reaction is composed of: 1-10×PCR Mix, 0.1-1 μM forward primer, 0.1-1 μM reverse primer, 0.1-0.5 μM probe and more than 1.0 ng / μl template nucleic acid.
9. A multiplex PCR detection method for mouse and rat viruses according to claim 8, characterized in that: The specific process of the fluorescent quantitative PCR amplification reaction is as follows: First, perform pre-denaturation at 92-97°C for 5-10 minutes; Then enter the polymerase chain reaction amplification stage, denaturation at 92-97°C for 10-30s, annealing and extension at 50-65°C for 10-30s, and perform 35-45 cycles.
10. A multiplex PCR detection method for rat and mouse viruses according to claim 9, characterized in that: In S5, the specific process of interpreting the fluorescence quantitative PCR results is as follows: The positive control product has an amplification curve and a Ct value of <35; Negative control products have no amplification curve or the amplification curve Ct value is ≥35; The GAPDH internal reference gene of the sample to be tested has an amplification curve and a Ct value of <35; When the sample to be tested has an amplification curve in the different fluorescence channels detected and the Ct value is less than 35, it is determined to be positive for the corresponding virus.
